News - Alexion Pharmaceuticals Inc.
HARTFORD, Conn., Oct. 29 /PRNewswire/ -- Marcum LLP, one of the nation's leading accounting and advisory firms, and The Connecticut Technology Council awarded winners in each of the six categories of the Marcum Tech Top 40 in a ceremony at the Chevrolet Theater in Wallingford, CT.
CHESHIRE, Conn., Jan. 12 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN), today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2008 on Thursday, February 12, 2009 before the financial markets open.
CHESHIRE, Conn., Jan. 5 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the 27th Annual JP Morgan Healthcare Conference in San Francisco at 4:30 p.m.
Alexion Licenses PDL's Queen et al. Patents for Soliris(R) INCLINE VILLAGE, Nev., and CHESHIRE, Conn., Jan. 5 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (Nasdaq: PDLI) and Alexion Pharmaceuticals, Inc.
